Arrowhead Pharmaceuticals <ARWR.O>: RBC Raises Target Price to $100 From $87
ARWR•Related News
Bausch + Lomb Q2 FY26 GAAP net loss narrows to $14 million; revenue rises 9% to $1.39 billion
BLCO•
Reynolds Consumer Products Q2 EPS USD 0.42
REYN•
OGE Energy Q2 FY26 earnings rise to $0.56 a share; net income climbs to $116.3 million
OGE•
AxoGen Q2 Revenue USD 69.7 Million Vs. IBES Estimate USD 67.1 Million
AXGN•
ADP FY26 net earnings rise 8% to $4.4 billion; revenue increases 7% to $21.9 billion
ADP•